About Vanguard Forums

Where Tomorrow’s Top Leaders Engage with Today’s CEOs

  • The Forums engage an elite, intimate group of invited senior leaders in a uniquely enriching dialogue with top tier CEOs, advisors and other experts. They share what works – and what does not – along with perspectives on leadership opportunities and challenges across their sectors.
  • The Forums develop critical top leadership insights, skills and capabilities through pragmatic learnings not found via conventional conferences or business school offerings.
  • The Forums define and develop solutions to key leadership issues, at a time of accelerating change and convergence among sectors.
  • The Forums build an active community of senior leaders that further advances individual capabilities and disruptive innovative leadership.

Sample Forum Agenda

  • Building High Performance Teams and Cultures
  • Leading in the Accelerating and Converging Environment: Building New Competencies and Capabilities
  • Managing Board Relations in an Era of Shareholder Activism
  • Learning and Adopting Best Practices from Other Companies and Industries
  • Workshop: Creating your Company Narrative
  • Cultivating a Culture of Digital Innovation: New Strategies on Leadership and Talent to Shape the Future of Your Industry

Who is Eligible to Participate?

Vanguard Forum delegates are chosen from across the global business ecosystem and include:

  • Top performers with CEO or C-Suite potential
  • Executives currently reporting to a CEO (level 2) or a CEO’s direct report (level 3)
  • High talent individuals who have recently taken, or are preparing to take, additional leadership responsibilities
  • VP/SVP or higher depending on the size and structure of the organization

Becoming a Forum Delegate

Delegates are accepted into the Vanguard Forums in two ways. The Forums extend direct invitations to high talent individuals identified by the advisory boards, faculty members and industry leaders.

The Member Company program enables organizations to integrate the Forums into their executive development process. Member companies nominate 1 to 4 executives annually to the Forums, and its follow-on curriculum. This ensures a pipeline of qualified, prepared individuals to advance into greater responsibility.

Member companies have the privilege of consulting on the Forum agendas and ongoing curriculum, as well as preferred pricing. To learn more, contact Vanguard.


A select number of industry-leading organizations are invited to collaborate on Vanguard Forums. While conventional acknowledgement and branding opportunities are available, Sponsor-Partners may also:

  • provide input into the program and meeting structure
  • assume roles as moderators or faculty members
  • influence faculty and delegate invitations
  • contribute to the ongoing curriculum

To explore partnership opportunities in the US, contact Vanguard. For EU events, contact Sarah Roberts.

Vanguard Forums Board of Advisors (Healthcare)

  • Goran Ando, Chairman, Novo Nordisk
  • Jeff Berkowitz Executive Vice President at UnitedHealth Group
  • Orlan Boston, EY Global Life Sciences & Healthcare Senior Partner
  • Eliot Forster, Chair of MedCity (London) and CEO, ImmunoCore
  • Ed Greissing, Executive director of the Lynda and Stewart Resnick Center for Public Health at the Milken Institute
  • Trevor Jones OBE, Visiting Professor, King’s College, London
  • Jeremy Levin, Chairman and CEO, Ovid; past CEO, Teva Pharmaceuticals
  • Byron Main, CEO, ExL Events
  • Vivek Ramaswamy, Founder, CEO and President, Roivant Sciences
  • Michael Watras, CEO, Straightline World

Selected Faculty Past and Present (Healthcare)

  • Goran Ando, Chairman of the Board, Novo Nordisk
  • Tony Coles, Chairman and CEO, Yumanity; past CEO, Onyx
  • Glen De Vries, President, Medidata Solutions
  • Mike Farrar, Former Chief Executive, NHS Confederation
  • Eliot Forster, CEO, Immunocore
  • Fred Hassan, Managing Director, Warburg Pincus; past CEO, Schering Plough
  • Trevor Jones, Visiting Professor, King’s College, London
  • Bob Langer, MIT Professor; U.S. Medal of Science awardee; global leader integrating biotech and materials science
  • Jeremy Levin, Chairman and CEO, Ovid; past CEO, Teva Pharmaceuticals
  • Ashley McEvoy, Group Company Chairman, J&J
  • David Pyott, Board Member, Philips; past Chairman and CEO, Allergan
  • Vivek Ramaswamy, Founder and CEO, Roivant Sciences, Inc.; founder and past CEO, Axovant Sciences
  • Brent Saunders, Chairman and CEO, Allergan
  • Chris Viehbacher, Managing Partner, Gurnet Point Capital; past CEO, Sanofi